407 related articles for article (PubMed ID: 17373187)
1. Outcomes associated with the use of biologic agents in moderate to severe psoriasis.
Price J; Bhosle M; Feldman SR; Balkrishnan R
J Drugs Dermatol; 2007 Mar; 6(3):259-67. PubMed ID: 17373187
[TBL] [Abstract][Full Text] [Related]
2. Disease and treatment burden of psoriasis: examining the impact of biologics.
Raval K; Lofland JH; Waters H; Piech CT
J Drugs Dermatol; 2011 Feb; 10(2):189-96. PubMed ID: 21283925
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
Alwawi EA; Krulig E; Gordon KB
Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
[TBL] [Abstract][Full Text] [Related]
4. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
Tzu J; Kerdel F
Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
[TBL] [Abstract][Full Text] [Related]
5. Pediatric psoriasis: updates in biologic therapies.
Sukhatme SV; Gottlieb AB
Dermatol Ther; 2009; 22(1):34-9. PubMed ID: 19222515
[TBL] [Abstract][Full Text] [Related]
6. Management and costs of severe psoriasis: the role of new biologics.
Feldman SR; Pearce DJ
Expert Rev Pharmacoecon Outcomes Res; 2004 Oct; 4(5):573-9. PubMed ID: 19807550
[TBL] [Abstract][Full Text] [Related]
7. [Psoriasis in the era of biologics].
Torres T; Velho GC; Sanches M; Selores M
Acta Med Port; 2010; 23(3):493-8. PubMed ID: 20654269
[TBL] [Abstract][Full Text] [Related]
8. Developments in systemic immunomodulatory therapy for psoriasis.
Berger EM; Gottlieb AB
Curr Opin Pharmacol; 2007 Aug; 7(4):434-44. PubMed ID: 17627886
[TBL] [Abstract][Full Text] [Related]
9. Do utilization management controls for phototherapy increase the prescription of biologics?
Simpson GL; Yelverton CB; Rittenberg S; Feldman SR
J Dermatolog Treat; 2006; 17(6):359-61. PubMed ID: 17853310
[TBL] [Abstract][Full Text] [Related]
10. [Use of biologicals in psoriasis].
Friedrich M; Philipp S; Sabat R; Asadullah K; Sterry W
Z Rheumatol; 2003 Oct; 62(5):439-49. PubMed ID: 14579031
[TBL] [Abstract][Full Text] [Related]
11. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
12. Treatment and management of psoriasis with nail involvement: a focus on biologic therapy.
Langley RG; Daudén E
Dermatology; 2010; 221 Suppl 1():29-42. PubMed ID: 20733313
[TBL] [Abstract][Full Text] [Related]
13. Long-term data in the treatment of psoriasis.
Thaçi D
Br J Dermatol; 2008 Aug; 159 Suppl 2():18-24. PubMed ID: 18700911
[TBL] [Abstract][Full Text] [Related]
14. [What are the objectives of moderate to severe psoriasis treatment?].
Ortonne JP
Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S281-4. PubMed ID: 18721665
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis.
Yentzer BA; Yelverton CB; Simpson GL; Simpson JF; Hwang W; Balkrishnan R; Feldman SR
Dermatol Online J; 2009 Apr; 15(4):1. PubMed ID: 19450394
[TBL] [Abstract][Full Text] [Related]
16. Scalp psoriasis: a review of current topical treatment options.
Papp K; Berth-Jones J; Kragballe K; Wozel G; de la Brassinne M
J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1151-60. PubMed ID: 17894698
[TBL] [Abstract][Full Text] [Related]
17. The treatment of moderate-to-severe psoriasis: prescreening and monitoring psoriatic patients on biologics.
Levine D; Strober BE
Semin Cutan Med Surg; 2010 Mar; 29(1):28-34. PubMed ID: 20430305
[TBL] [Abstract][Full Text] [Related]
18. Adherence to adalimumab in patients with moderate to severe psoriasis.
West C; Narahari S; O'Neill J; Davis S; Huynh M; Clark A; Boles A; Feldman SR
Dermatol Online J; 2013 May; 19(5):18182. PubMed ID: 24011280
[TBL] [Abstract][Full Text] [Related]
19. Combining traditional systemic and biologic therapies for psoriasis.
Heffernan MP
Semin Cutan Med Surg; 2010 Mar; 29(1):67-9. PubMed ID: 20430311
[TBL] [Abstract][Full Text] [Related]
20. New biologics for psoriasis and psoriatic arthritis.
Rozenblit M; Lebwohl M
Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
